MedComm

MedComm is a peer-reviewed, online open access journal that publishes the pioneer works providing novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. The journal emphasizes original findings that advance the understanding of pathogenesis or improve the diagnosis and treatment of human disease. Interdisciplinary studies utilizing approaches of molecular biology, cell biology, chemistry, pharmacology or material science to address the issues of clinical, basic and translational medicines are particularly encouraged. MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques.

MedComm是同行评审的在线开放获取期刊，及时发表具有新颖性的、对人类健康有重要意义的开创性医学研究。该期刊重视原创性发现，旨在促进对发病机制的理解及改善对人类疾病的诊断与治疗，尤其青睐利用分子生物学、细胞生物学、化学、药理学或材料科学方法解决临床、基础和转化医学问题的跨学科研究。MedComm关注的主题包括但不限于临床医学、分子诊断、表观遗传学/遗传学、细胞生物学、药物发现、进化医学、纳米技术和人工智能。该期刊聚焦疾病特征、致病机制和医学技术的临床与实验进展。